References
- Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. and Frei, E. 3rd. Intensive post-remission chemotherapy in adult with acute myeloid leukemia, Cancer and Leukemia Group B. N. Engl. J. Med. 331: 896-903, 1994. https://doi.org/10.1056/NEJM199410063311402
- Hoffman, R., Benz, E.J. Jr., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. and McGlave, P. Hematology. Basic principles and practice. 3rd ed., New York, Churchill Livingstone, p 1577, 2000.
- Pharmacopoeia of the People's Republic of China, Vol. I; Chemical Industry Press: Beijing p 65, 2000.
- Yoon, S.H., Ju, S.M., Kim, N.S., Park, S.C., Kim, S.H., Song, Y.S. and Jeon, B.H. Extracellular Signal-regulated Kinase(ERK) is Required for Water Extract of Nardostachys chinersis-Induced Differentiation in HL-60 Cells Kor. J. Ori. Physi. Patho. 20: 1415-1320, 2006.
- Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E., Salmon, M. and Lord, J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256: 34-41, 2005.
- Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K. and Cobb, M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22: 153-183, 2001. https://doi.org/10.1210/er.22.2.153
- Cobb, M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71: 479-500, 1999. https://doi.org/10.1016/S0079-6107(98)00056-X
- Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E.Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995. https://doi.org/10.1126/science.270.5240.1326
- Caponigro, F., French, R.C. and Kaye, S.B. Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 8: 26-33, 1997. https://doi.org/10.1097/00001813-199701000-00003
- Nishikawa, M. and Shirakawa, S. The expression and possible roles of protein kinase C in haematopoietic cells. Leuk. Lymphoma 8: 201-211, 1992. https://doi.org/10.3109/10428199209054906
- Komada, F., Nishikawa, M., Uemura, Y., Morita, K., Hidaka, H. and Shirakawa, S. Expression of three major protein kinase C isozymes in various types of human leukemic cells Cancer Res. 51: 4271-4278, 1991.
- Tsiftsoglou, A.S., Pappas, I.S. and Vizirianakis, I.S. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol. Ther. 100: 257-290, 2003. https://doi.org/10.1016/j.pharmthera.2003.09.002
- Zhang, Y., Lu, Y., Zhang, L., Zheng, Q.T., Xu, L.Z. and Yang, S.L.from the roots and rhizomes of Nardostachys chinensis. J. Nat. Prod. 68: 1131-1133, 2005. https://doi.org/10.1021/np050125n
- Tanitsu, M.A., Takaya, Y., Akasaka, M., Niwa, M. and Oshima, Y. Guaiane- and aristolane-type sesquiterpenoids of Nardostachys chinensis roots. Phytochemistry 59: 845-849, 2002. https://doi.org/10.1016/S0031-9422(01)00469-1
- Li, P., Yamakuni, T., Matsunaga, K., Kondo, S. and Ohizumi, Y. Nardosinone enhances nerve growth factor-induced neurite outgrowth in a mitogen-activated protein kinase- and protein kinase C-dependent manner in PC12D cells. J. Pharmacol. Sci. 93: 122-125, 2003. https://doi.org/10.1254/jphs.93.122
- 구병수, 김대근, 최정현, 이동웅 감송향 정유성분의 흡입 및 경구투여시의 중추신경 억제효과. 생명과학회지 16: 156-161, 2006.
-
Lee, S.J., Choi, Y.H. and Choi, B.T. Inhibitory Effects of Aqueous Extracts from Nardostachys chinensis on
$alpha$ -Melanocyte Stimulating Hormone-induced Melanogenesis in B16F10 Cells. Integrative Biosci. 10: 223-236, 2006. - 박철, 정민, 서은아, 권강범, 유도곤 감송향물추출물의 HO-1 발현 촉진을 통한 세포보호 작용 및 항염효과. 동의생리병리학회지24: 624-629, 2010.
- 백설, 최재혁, 고성훈, 이용재, 차동석, 박은영, 강양규 전훈 감송향의 in vitro 항산화 및 항염증 효과. 동의생리병리학회지 23: 853-859, 2009.
- 오광우, 정지해, 정현철, 조한백, 김송백, 최창민감송향이 수지상세포 성숙에 미치는 영향. 대한한방부인과학회지 23: 14-25, 2010.
- Furukawa, Y., Uenoyama, S., Ohta, M., Tsunoda, A., Griffin, J.D. and Saito, M.Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J. Biol. Chem. 267: 17121-17127, 1992.
- Hui, E.K. and Yung, B.Y. Cell cycle phase-dependent effect of retinoic acid on the induction of granulocytic differentiation in HL-60 promyelocytic leukemia cells. Evidence for sphinganine potentiation of retinoicacid-induced differentiation. FEBS Lett. 318: 193-199, 1993. https://doi.org/10.1016/0014-5793(93)80020-U
- Cooper, S. Revisiting the relationship of the mammalian G1 phase to cell differentiation. J. Theor. Biol. 208: 399-402, 2001. https://doi.org/10.1006/jtbi.2000.2228
- Dimberg, A. and Oberg, F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk. Lymphoma 44: 1641-1650, 2003. https://doi.org/10.1080/1042819031000083316
- Caponigro, F., French, R.C. and Kaye, S.B. Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 8: 26-33, 1997. https://doi.org/10.1097/00001813-199701000-00003
- Nishikawa, M. and Shirakawa, S. The expression and possible roles of protein kinase C in haematopoietic cells. Leuk. Lymphoma 8: 201-211, 1992. https://doi.org/10.3109/10428199209054906
- Yen, A., Roberson, M.S., Varvayanis, S. and Lee, A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58: 3163-3172, 1998.
- Yen, A., Roberson, M.S. and Varvayanis, S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev. Biol. Anim. 35: 527-532, 1999. https://doi.org/10.1007/s11626-999-0063-z
- Wang, X. and Studzinski, G.P. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J. Cell Biochem. 80: 471-482, 2001. https://doi.org/10.1002/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J
- Wang, X., Rao, J. and Studzinski, G.P. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiationof human leukemia HL60 cells. Exp. Cell Res. 258: 425-437, 2000. https://doi.org/10.1006/excr.2000.4939
- Wang, X. and Studzinski, G.P. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J. Cell Biochem. 82: 68-77, 2001. https://doi.org/10.1002/jcb.1141
- Miranda, M.B., McGuire, T.F. and Johnson, D.E. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16: 683-692, 2002. https://doi.org/10.1038/sj.leu.2402400
- Yen, A., Roberson, M.S., Varvayanis, S. and Lee, A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58: 3163-3172, 1998.
- Gate, L., Lunk, A. and Tew, K.D. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor. Biochem. Pharmacol. 65: 1611-1622, 2003. https://doi.org/10.1016/S0006-2952(03)00152-7
- Jaken, S. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8: 168-173, 1996. https://doi.org/10.1016/S0955-0674(96)80062-7
- Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1998.
-
MacFarlane, D.E. and Manzel, L. Activation of
$\beta$ -isozyme of protein kinase C ($PKC\beta$ ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J. Biol. Chem. 269: 4327-4331, 1994. - Nishikawa, M., Komada, F., Uemura, Y., Hidaka, H. and Shirakawa, S. Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol diester. Cancer Res. 50: 621-626, 1990.
-
Tonetti, D.A., Henning-Chubb, C., Yamanishi, D.T. and Huberman, E. Protein kinase C-
$\beta$ isrequired for macrophage differentiation of human HL-60 leukemia cells. J. Biol. Chem. 269: 23230-23235, 1994. - Tonetti, D.A., Horio, M., Collart, F.R. and Huberman, E. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation. Cell Growth Differ. 3: 739-745, 1992.
- Kiley, S.C., Adams, P.D. and Parker, P.J. Cloning and characterization of phorbol ester differentiation-resistant U937 cell variants. Cell Growth Differ. 8: 221-230, 1997.
- Hass, R., Hirano, M., Kharbanda, S., Rubin, E. and Kufe, D. Resistance to phorbol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Cell Growth Differ. 4: 657-663, 1993,
- Yang, K.D., Kharbanda, S., Datta, R., Huberman, E., Kufe, D. and Stone, R. All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line. Blood 83: 490-496, 1994.
- Kim, S.H., Oh, S.M. and Kim, T.S. Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone. Eur. J. Pharmacol. 511: 89-97, 2005. https://doi.org/10.1016/j.ejphar.2005.02.008
- Kim, S.H., Kim, H.J. andKim, T.S. Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. Eur. J. Pharmacol. 482: 67-76, 2003. https://doi.org/10.1016/j.ejphar.2003.09.057
- Kang. S.N., Lee, M.H., Kim, K.M., Cho, D. and Kim, T.S. Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase C.Biochem. Pharmacol. 61: 1487-1495, 2001. https://doi.org/10.1016/S0006-2952(01)00626-8